Wang SJ, O’Neill RT, Hung HMJ.Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset. Pharmaceut Stat2007; 6: 227-44.
2.
Simon R., Wang SJUse of genomic signatures in therapeutics development in oncology and other diseases. Pharmacogenom J2006; 6: 166-73.
3.
Wang SJBiomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI. Pharmaceut Stat2007 ; 6: 283-96.
4.
Wang SJ, Hung HMJ, O’Neill RTAdaptive patient enrichment designs in therapeutic trials. Biometr J2009; 51: 358-74.
